20/20 Biolabs, Inc.
AIDX
$0.52
$0.000.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.55M | 4.22M | 1.03M | 1.14M | 1.02M |
| Total Receivables | 291.50K | 201.50K | 200.00K | 136.90K | 174.30K |
| Inventory | 111.00K | 104.50K | 116.20K | 54.80K | 61.70K |
| Prepaid Expenses | 127.00K | 175.20K | 129.00K | 229.30K | 152.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.08M | 4.70M | 1.47M | 1.57M | 1.41M |
|
|
|||||
| Total Current Assets | 5.08M | 4.70M | 1.47M | 1.57M | 1.41M |
| Net Property, Plant & Equipment | 553.00K | 607.70K | 662.00K | 718.00K | 774.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 471.50K | 472.30K | 473.40K | 479.80K | 486.30K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.10K | 23.10K | 1.53M | 475.80K | 23.10K |
| Total Assets | 6.12M | 5.80M | 4.14M | 3.24M | 2.70M |
|
|
|||||
| Total Accounts Payable | 1.03M | 980.50K | 868.50K | 628.40K | 556.60K |
| Total Accrued Expenses | 864.70K | 652.50K | 785.80K | 601.60K | 537.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 192.70K | 496.40K | 250.60K | 173.30K | 170.80K |
| Total Finance Division Other Current Liabilities | 467.00K | 450.70K | 558.30K | 588.80K | 380.50K |
| Total Other Current Liabilities | 467.00K | 450.70K | 558.30K | 588.80K | 380.50K |
| Total Current Liabilities | 2.55M | 2.58M | 2.46M | 1.99M | 1.65M |
|
|
|||||
| Total Current Liabilities | 2.55M | 2.58M | 2.46M | 1.99M | 1.65M |
| Long-Term Debt | -- | -- | 619.40K | 450.50K | 71.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 379.70K | 429.10K | 488.70K | 536.00K | 582.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.90K | 37.10K | 585.40K | 152.40K | 45.80K |
| Total Liabilities | 2.96M | 3.05M | 4.16M | 3.13M | 2.35M |
|
|
|||||
| Common Stock & APIC | 38.55M | 37.97M | 33.18M | 32.00M | 30.99M |
| Retained Earnings | -36.93M | -35.42M | -33.25M | -31.94M | -30.69M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.62M | 2.55M | -66.40K | 61.30K | 304.40K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.54M | 204.20K | 47.20K | 47.20K | 47.20K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.54M | 204.20K | 47.20K | 47.20K | 47.20K |
|
|
|||||
| Total Common Equity | 1.62M | 2.55M | -66.40K | 61.30K | 304.40K |
| Total Preferred Equity | 1.54M | 204.20K | 47.20K | 47.20K | 47.20K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.16M | 2.76M | -19.20K | 108.50K | 351.60K |
|
|
|||||